ArticleHeliyon2024

CHRDL2 activates the PI3K/AKT pathway to ameliorate glucocorticoid-induced damages to bone microvascular endothelial cells (BMECs).

Xianzhe Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.